| 1 |
Oculis Holding AG |
66,380.63 Bn |
66,380.34 Bn |
- |
-5.07% |
| 2 |
Nanobiotix |
1,910.39 Bn |
1,910.33 Bn |
- |
- |
| 3 |
Akari Therapeutics |
959.56 Bn |
959.56 Bn |
- |
- |
| 4 |
BeOne Medicines |
470.95 Bn |
466.16 Bn |
1.35 Bn |
33.08% |
| 5 |
Vertex Pharmaceuticals |
121.97 Bn |
114.72 Bn |
2.59 Bn |
16.64% |
| 6 |
Regeneron Pharmaceuticals |
69.92 Bn |
61.16 Bn |
3.31 Bn |
-7.60% |
| 7 |
Belite Bio |
62.06 Bn |
62.06 Bn |
- |
- |
| 8 |
Argenx Se |
55.76 Bn |
50.58 Bn |
1.41 Bn |
- |
| 9 |
Alnylam Pharmaceuticals |
37.50 Bn |
34.49 Bn |
959.66 Mn |
34.32% |
| 10 |
Fortrea Holdings |
1.82 Bn |
1.68 Bn |
123.60 Mn |
-104.08% |
